Paper & Presentations [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-03-30 01:33 (1304 d 04:09 ago) – Posting: # 18622
Views: 8,414

Hi John,

» If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)

[image]Too much absinthe? I guess you mean this goody:

Yu LX, Jiang W, Zhang X, Lionberger R, Makhlouf F, Schuirmann DF, Muldowney L, Chen M-L, Davit B, Conner D, Woodcock J. Novel Bioequivalence Approach for Narrow Thera­peutic Index Drugs. Clin Pharmacol Ther. 2015;97(3):286–91. doi:10.1002/cpt.28.


» Anyhow, Have you looked at this FDA slide presentation before?
» NTI

Yep. There are others with more background information. Most simulations were performed in R – Donald told me in 2016 that he grew up with APL and finds R difficult… See also this post. The presentations are gone with the wind. Webarchive [image] #1 (June 2017), [image] #2 (July 2017). In #1 navigate to page 51 and in #2 to page 57.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,753 posts in 4,548 threads, 1,544 registered users;
online 23 (0 registered, 23 guests [including 5 identified bots]).
Forum time: Sunday 05:42 CEST (Europe/Vienna)

They were “so intent of making everything numerical”
that they frequently missed seeing
what was there to be seen.    Barbara McClintock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5